MMS Holdings Expert Insights Blog
Experts at MMS share their insights on trending
topics in the pharmaceutical industry.
Former Astellas VP of Biostatistics Joins MMS as Principal Advisor of Biostatistics
CANTON, Mich. (November 18, 2021) – MMS Holdings – a data-focused CRO – announced this week the addition of Kevin Chartier, Ph.D., as Principal Advisor of Biostatistics and Submissions Planning. Chartier will work with the biostatistics team across MMS global...
MMS Holdings is the Winner of The Michigan Top Workplaces 2021 Award
CANTON, Mich. (11/15/2021) – MMS has been named a 2021 award winner of the Michigan Top Workplaces by the Detroit Free Press Top Workplaces. The award is based solely on employee feedback from an anonymous survey measuring 15 culture drivers that are critical to the...
Second Annual Global Champions of Change Competition Winner
MMS has just concluded its second annual Global Champions of Change Competition (G3C), where colleagues from all MMS regions submitted innovative ideas based on our tradition of providing high-quality, efficient services to our clients to help discover and market...
Praxis bioresearch seeks support from MMS for Alzheimers Disease Therapeutics
SACRAMENTO, Calif. (October 28, 2021) - MMS Holdings (MMS) – a data-focused CRO – provided regulatory strategy support to Praxis Bioresearch in the development of a therapeutic for apathy in Alzheimer’s disease. This comes as Praxis was awarded a $2.9 Million...
How to use a Master Protocol to gain Efficiencies in a Clinical Trial
The clinical development industry is an ever-changing field. It’s crucial to stay ahead of industry changes and ensure compliance with the needs of health authorities. Experienced medical writers understand the purpose of a trial and work closely with the study team...
MMS SmartStart™ Tech-Enabled Solution Eases Document Content Creation Process
CANTON, Mich. (September 22, 2021) - MMS Holdings Inc. (MMS) - an award-winning, data-focused CRO – announced the release of SmartStart™ Tech-Enabled Templates to reduce time and effort in the document content creation process while increasing the quality...
Challenges of Rare Disease Drug Development Programs
Why is drug development and research in the context of rare disease frequently more difficult to address? In this blog, we will outline some of the challenges with rare disease programs. What is a rare disease? Simply put, a rare disease or condition is one that...
Tips for Successful Medical Device Development and Approval
For Sponsors planning to manufacture or distribute a medical device in the US, understanding regulatory requirements is of the utmost importance. Medical device development and approval are regulated by the FDA, under the jurisdiction of the Center for Devices and...
How to Train Users on the Clinical Trial Information System (CTIS) Ahead of New Regulations
How to Train Users on the Clinical Trial Information System (CTIS) Ahead of New Regulations On 31 July 2021, the European Commission published a notice in the Official Journal of the European Union announcing that the EU Portal and Database, a key component of the...